Macular Degeneration In America
New Health Union survey data helps the healthcare industry better understand and reach people living with macular degeneration
For the second year in a row, Health Union has gathered patient-reported data from hundreds of real people impacted by macular degeneration. The second annual Macular Degeneration In America survey quantifies the true impact of this condition among patients – going beyond basic demographics and symptoms to establish a deep understanding of the holistic patient journey for those affected and to track trends over time.
The new data from the second annual Macular Degeneration In America survey reveals deep insights of a population of 800 diagnosed respondents, of which 79% have had a procedure for their macular degeneration and 45% feel controlled on their current treatment plan.* 28% have been diagnosed with both wet and dry AMD, and 66% have accepted their diagnosis.*
*Top 2 box on a 7-pt. scale
In the survey, people living with macular degeneration share their emotional experiences by reflecting on life before AMD:
“I hate the independence I have lost. My husband has health issues. I am very healthy but I just can’t see. Very confining.” – MacularDegeneration.net community member
“I wish that information on AMD had been available at a far younger age, especially the need for vitamins for the eyes.” – MacularDegeneration.net community member
This access to a broad base of knowledge, facts and data gleaned from Health Union’s open online health communities like MacularDegeneration.net, and syndicated research allows the healthcare industry to harness the power of Health Union’s continuous immersion in the patient experience to deliver smarter insights and implications–so you can spend your time developing the strategies that will make a difference.